FIELD: medicine, pharmacology. SUBSTANCE: the suggested pharmaceutical preparation contains the mixture of bismuth citrate and alginate and any reactionally obtained products, especially bismuth alginate. Moreover, the suggested preparation may contain one or more antibiotic substance. Reaction medium could be supplemented with a calcium- containing component, for example, calcium chloride, to form microcapsules of calcium alginate which will act as a slowly released covering. The present preparation could, also, contain an agent such as, for example, sodium bicarbonate. The innovation provides efficiency to remove Campylobacter such as Heliobacterpylori, then it should actively prevent the reflux of gastric content. EFFECT: higher efficiency of therapy. 6 cl, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
TREATMENT OF INFLAMMATORY GASTROINTESTINAL DISEASED ASSOCIATED WITH HELICOBACTER PYLORI | 2004 |
|
RU2278682C2 |
METHOD OF TREATING CHRONIC GASTRODUODENITIS ASSOCIATED WITH INFECTION CAUSED BY BACTERIA Helicobacter pylori IN ALLERGIC DISEASES | 2011 |
|
RU2472498C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING GASTROESOPHAGEAL REFLUX DISEASE | 2012 |
|
RU2501549C1 |
DIAGNOSTIC TECHNIQUE FOR DEGREE OF ACTIVITY OF ANTRAL HELICOBACTER-ASSOCIATED GASTRITIS IN PATIENTS WITH BRONCHIAL ASTHMA | 2009 |
|
RU2394499C1 |
METHOD OF STOMACH ULCER TREATMENT | 2006 |
|
RU2329810C1 |
PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF HELICOBACTER PYLORI | 2014 |
|
RU2671400C2 |
METHOD FOR TREATMENT OF STOMACH AND DUODENUM ULCEROUS DISEASE | 2006 |
|
RU2294204C1 |
PHARMACEUTICAL COMPOSITION AND METHOD OF GASTROENTERIC SICKNESS TREATMENT AND PROPHYLAXIS | 1995 |
|
RU2076708C1 |
METHOD OF TREATING HELICOBACTER PYLORI INFECTION IN ADULTS | 2019 |
|
RU2699567C1 |
METHOD FOR TREATING HELICOBACTER PYLORI-ASSOCIATED ULCEROUS GASTRIC AND DUODENAL DISEASE | 2006 |
|
RU2308949C1 |
Authors
Dates
2002-11-27—Published
1997-03-27—Filed